4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease
Key Takeaways
- ACOG's 2024 update suggests forgoing routine Rh testing and RhD immune globulin for abortion or pregnancy loss before 12 0/7 weeks; where local protocol still directs it, the dose is 50 mcg before 12 weeks and 300 mcg at 12 weeks or later.
- Medical management of early pregnancy loss with mifepristone 200 mg followed 24 hours later by misoprostol 800 mcg exceeds 90 percent success, outperforming misoprostol alone.
- A complete hydatidiform mole is androgenetic 46,XX with no fetal tissue, a snowstorm ultrasound pattern, and hCG often above 100,000 mIU/mL, while a partial mole is triploid with fetal tissue and near-normal hCG.
- After molar evacuation, hCG is followed weekly until negative on three consecutive tests and then monthly for 6 months, with reliable contraception required throughout surveillance.
- Septic abortion is a surgical emergency requiring broad-spectrum intravenous antibiotics plus immediate uterine evacuation, not antibiotics alone.
Obstetric complications during the antepartum period require prompt clinical recognition, accurate differential diagnosis, and decisive action. Whether addressing early pregnancy bleeding, life-threatening third-trimester hemorrhage, alterations in amniotic fluid volume, or the onset of preterm labor, the Certified Nurse-Midwife operates as both primary clinician and collaborative partner within the perinatal care team.
First-Trimester Vaginal Bleeding & Early Pregnancy Loss
Vaginal bleeding occurs in approximately 20% to 25% of all pregnancies during the first trimester. The primary clinical differential diagnosis includes spontaneous abortion, ectopic pregnancy, gestational trophoblastic disease, and benign cervical/vaginal pathology (e.g., cervical polyp, ectropion, infection).
Spontaneous Abortion Categories & Clinical Findings
Early pregnancy loss is defined as a nonviable, intrauterine pregnancy with either an empty gestational sac or an embryo/fetus without cardiac activity prior to 12 6/7 weeks gestation.
| Classification | Cervical Internal Os | Vaginal Bleeding & Cramping | Ultrasound Findings | Clinical Management |
|---|---|---|---|---|
| Threatened Abortion | Closed | Mild to moderate vaginal bleeding; mild or no pelvic cramping | Viable intrauterine embryo with documented fetal cardiac activity | Expectant management; reassurance; pelvic rest; administer RhIG if Rh-negative; avoid bed rest (no proven benefit) |
| Inevitable Abortion | Open | Moderate to heavy vaginal bleeding; progressive cramping | Gestational sac low in uterus or cervical canal; cardiac activity may or may not be present | Expectant, medical (mifepristone + misoprostol), or surgical uterine evacuation; pain control |
| Incomplete Abortion | Open | Heavy bleeding with passage of tissue; severe cramping | Retained products of conception (thickened, irregular endometrial tissue >15 mm); gestational sac collapsed | Medical evacuation or surgical aspiration (MVA/EVA); monitor for hemodynamic instability and hemorrhage |
| Complete Abortion | Closed (or closing) | History of heavy bleeding and tissue passage; symptoms now subsiding | Empty endometrial cavity; stripe thickness typically <15 mm; no retained tissue | Expectant; confirm serial falling hCG to zero; emotional support; contraception counseling |
| Missed Abortion | Closed | Minimal or no bleeding; cessation of pregnancy symptoms | Nonviable intrauterine pregnancy (embryo ≥7 mm without cardiac activity or sac mean diameter ≥25 mm without embryo) | Expectant, medical, or surgical management; discuss patient preference and timeframe |
| Septic Abortion | Typically open with purulent discharge | Bleeding variable; severe cramping; uterine tenderness; fever (>38.0°C), foul odor, leukocytosis | Retained products of conception; intraabdominal free fluid; gas in uterine cavity | Medical emergency: broad-spectrum IV antibiotics (e.g., ampicillin + gentamicin + clindamycin) and immediate surgical curettage |
Treatment Modalities for Early Pregnancy Loss
For stable patients without infection or heavy hemorrhage, three management strategies exist:
- Expectant Management: Safe for up to 2 to 4 weeks in stable patients with threatened, incomplete, or missed abortion. Complete expulsion occurs in 70% to 80% within this window, though unpredictable timing and bleeding are disadvantages.
- Medical Management: Combining a progesterone receptor antagonist with a prostaglandin analogue yields superior efficacy (>90% success) compared to prostaglandin alone:
- Mifepristone: 200 mg PO single dose, followed 24 hours later by:
- Misoprostol: 800 mcg buccally or vaginally (repeated once at 48 hours if expulsion is incomplete).
- Side effects: Cramping, heavy bleeding, nausea, vomiting, diarrhea, and low-grade pyrexia.
- Surgical Management: Manual vacuum aspiration (MVA) under local paracervical anesthesia or electric vacuum aspiration (EVA) in the operating room. Indicated for severe hemorrhage, hemodynamic instability, intrauterine infection, suspected molar gestation, or patient preference.
- Rh Alloimmunization Prophylaxis: All unsensitized Rh-negative individuals with first-trimester bleeding or loss must receive Rh immune globulin (RhIG) within 72 hours of bleeding onset: 50 mcg IM for gestational age <12 0/7 weeks; 300 mcg IM for gestational age ≥12 0/7 weeks.
Gestational Trophoblastic Disease (Hydatidiform Mole)
Gestational trophoblastic disease encompasses a spectrum of cellular proliferations arising from placental villous trophoblast.
- Complete Hydatidiform Mole: Results from the fertilization of an enucleated ovum by a single sperm that duplicates its DNA (46,XX, androgenetic) or by two sperm (46,XY). Characterized by total absence of embryonic/fetal tissue, diffuse trophoblastic hyperplasia, generalized hydropic villi, and markedly elevated beta-hCG levels (often >100,000 mIU/mL). Classic ultrasound displays a "snowstorm" or "bunch of grapes" intrauterine pattern. Clinical features include hyperemesis gravidarum, early-onset preeclampsia (<20 weeks), theca lutein ovarian cysts, and clinical hyperthyroidism.
- Partial Hydatidiform Mole: Results from fertilization of a normal ovum by two sperm, yielding a triploid karyotype (69,XXX, 69,XXY, or 69,XYY). Contains fetal tissue alongside localized hydropic villi. Beta-hCG levels are typically mildly elevated or normal, and presentation mimics an incomplete or missed abortion.
- Management: Suction curettage evacuation under ultrasound guidance. Baseline chest radiograph is obtained to rule out pulmonary trophoblastic embolization. Serial quantitative beta-hCG levels are tracked weekly until negative for three consecutive weeks, then monthly for 6 months to monitor for persistent gestational trophoblastic neoplasia (choriocarcinoma). Reliable contraception is strictly mandated throughout surveillance.
[!NOTE] 2024 update on RhD immune globulin before 12 weeks. ACOG's Clinical Practice Update (2024) and a concurrent SMFM statement now suggest forgoing routine Rh testing and RhD immune globulin for abortion or pregnancy loss at less than 12 0/7 weeks, because the likelihood of alloimmunization at that gestational age is very low and the prior recommendation rested on very low-quality evidence. The 50 mcg mini-dose described above remains the correct dose wherever local or state protocol still directs administration, and the 300 mcg dose remains standard at 12 0/7 weeks and beyond. Know which protocol governs your practice, and be able to explain the change to a patient who has heard the older rule.
A patient at 9 weeks gestation presents with heavy vaginal bleeding and severe cramping. The cervical os is open, tissue is visible at the os, and ultrasound shows a collapsed gestational sac with an irregular endometrial thickness of 22 mm. She is Rh-negative, unsensitized, and hemodynamically stable. Which classification and management plan is correct?